Karen Knudsen, MBA PhD, Appointed Chief Executive Officer of the Parker Institute for Cancer Immunotherapy

The Parker Institute for Cancer Immunotherapy (PICI) today announced the appointment of Karen E. Knudsen, MBA, PhD, as its new Chief Executive Officer. A visionary leader in oncology, healthcare delivery, scientific innovation and strategic transformation, Dr. Knudsen joins PICI at a pivotal time, and brings significant expertise in converting scientific discoveries into real world benefit for cancer patients. Despite recent groundbreaking advancements, like CRISPR gene editing and mRNA vaccines, the life sciences industry is facing unprecedented challenges that undermine scientific progress and threaten to short-circuit the engine of scientific discovery. As the institute nears its 10-year anniversary, it is primed to strengthen support of the scientific community and escalate capacity to drive immune-based therapeutic breakthroughs for cancer.